Menu
Recruiting NCT06806735

Measuring the Volumes of Hypertrophic Scars and Keloids, Two Specific Kind of Scars, Over Different Points in Time in Patients Who Have Undergone Surgery and Evaluate 3D-cameras As a Possible Measuring and Documenting Tool Including Volumetry

Observational Keloid Scar Following Surgery Scars, Hypertrophic Scar Keloid

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: 3D-Pictures.
Who it may be relevant to
Registry conditions: Keloid Scar Following Surgery, Scars, Hypertrophic, Scar Keloid. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Switzerland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Quantification of Hypertrophic Scar Tissue or Keloid Using a 3D-Camera

Overview

Measuring the volumes of hypertrophic scars and keloids, two specific kind of scars, over different points in time in patients who have undergone surgery and evaluate 3D-cameras as a possible measuring and documenting tool including volumetry.

Detailed description

The objective of this study is to utilize a 3D camera to measure the volumes of hypertrophic scars and keloids in patients at specified time points. The time points for measurement include day 0, as well as 3, 6, and 12 months. The 3D camera will be evaluated for their efficacy in measuring and documenting the volumes of the scars. This evaluation will include volumetry, which is the measurement of the three-dimensional space occupied by an object.

Interventions

  • Other 3D-Pictures
    3D-Pictures will be taken of hypertrophic scars and keloids to document them.

Primary outcome measures

  • Measurability [Time frame: Day 0, Month 3, 6 and 12]

Eligibility criteria

Inclusion criteria

  • All patients with hypertrophic scars or keloids, written consent to participate in the study, minimum age of 18 years.

Exclusion criteria

  • Absence of written consent, unwillingness to contribute data, inability to understand the study protocol.
  • lack of hypertrophic scars or keloid

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Switzerland · 1 center
  • Universitätsspital Zürich — Zurich

Identifiers

NCT: NCT06806735 · 2024-01147

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗